Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/2010
Title: Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer.
Epworth Authors: Harewood, Laurence
Lawrentschuk, Nathan
Troy, Andrew
Webb, David
Chan, Yee
Murphy, Declan
Tran, Ben
Other Authors: Anton, Angelyn
Hasan, Olfat
Ballok, Zita
Bowden, Patrick
Costello, Anthony
Dundee, Phil
Peters, Justin
See, Andrew
Shankar, Siva
Hofman, Michael
Keywords: Prostate-Specofic Membrane Antigen
PSMA
Positron-Emission Tomography
PET/CT
Metastatic Prostate Cancer
Upfront Chemohormonal Therapy
Metabolic Response
Prognostic Marker
Chemotherapy
Epworth Cancer Services Clinical Institute
Epworth Urology and Vascular Clinical Institute
Issue Date: Oct-2020
Publisher: Wiley
Citation: BJU Int . 2020 Oct;126(4):433-435
Abstract: Our study investigated the use of Prostate-specific membrane antigen (PSMA) positron-emission tomography (PET/CT) in patients with metastatic prostate cancer who received upfront chemohormonal therapy. The aim was to compare metabolic response assessed by PSMA PET/CT with the established favourable prognostic marker of PSA ≤0.2 ng/mL following chemotherapy.
URI: http://hdl.handle.net/11434/2010
DOI: 10.1111/bju.15151
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/32579772/
ISSN: 1464-410X
Journal Title: BJU International
Type: Journal Article
Affiliated Organisations: Walter and Eliza Hall Institute, Melbourne, Vic., Australia.
Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada.
Healthcare Imaging Services, Melbourne, Vic., Australia.
ICON Cancer Care, Melbourne, Vic., Australia.
Royal Melbourne Hospital, Melbourne, Vic., Australia.
Australian Prostate Centre, Melbourne, Vic., Australia.
Department of Surgery, University of Melbourne, Melbourne, Vic., Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic., Australia.
Type of Clinical Study or Trial: Cohort Study
Appears in Collections:UroRenal, Vascular

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.